IFNG and neoplasm: Each clone was responsive to tumor-derived peptide presented by a autologous (HLA-II+) B lymphoblastoid cell line (data not shown) or T2-DR1 cells in co-culture IFN-γ ELISpot assays (Fig. 2A).